Banker Haris Santana argues that apps have made banking quicker, but customer trust is still won by people who explain, help and act when something goes wrong.
Mobile apps have taken much of the waiting out of banking.
FI Works founder Keith Henkel says community banks and credit unions have the data, but lack a way to turn a warning sign into a call to the right person.
FI Works, which builds a relationship intelligence and engagement platform for community banks and credit unions, has launched Signals, a feature that uses machine learning to spot households likely to add a product, take up digital services or leave the
Netcall's Pol Brouckaert argues that as AI makes fake documents easier to produce, checks on whether evidence can be trusted must sit inside workflows.
Businesses have spent years automating the processing of claims, applications and supporting documents.
ISN's ISNetworld platform has standardised contractor compliance across four Honeywell Mexico sites, signalling broader industrial digitisation in Latin America.
ISN's ISNetworld platform has standardised contractor compliance across four Honeywell Mexico sites, signalling broader industrial digitisation in Latin America.
WeFi CEO Maksym Sakharov discusses what MiCA got right, the cost of compliance and why Europe cannot regulate stablecoin demand away.
MiCA, the EU’s Markets in Crypto-Assets Regulation, has given crypto firms a single European rulebook and, with it, a bill. As the framework takes full effect, the loudest voices in the debate have been stablecoin issuers and exchanges.
Stablecoins are growing fastest where they solve real problems—especially inflation, foreign exchange access, and slow payments—and Turkey shows why that utility could re
If you want to understand where stablecoin adoption is really headed, Turkey is one of the clearest places to look.
Nasdaq-listed Solmate says it plans to resell UAE-sourced GPU capacity for AI training and inference, with payment options including Solana stablecoins.
The EMA's advisory committee recommended secukinumab for patients aged 12 and over with moderate to severe hidradenitis suppurativa, with an EC decision expected within